Kenza Health Hub logoGet Started
1 May 2026Oral drugsSource update: February 2024

Digoxin Oral: Dosing and Precautions

Digoxin guidance for supraventricular arrhythmias and heart failure, with narrow therapeutic window precautions.

Also searched as

Digoxin
Prescription under medical supervision

Source reviewed

February 2024

Guide category

Oral drugs

Safety boundary

Prescription medicine information for clinician-guided use.

Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.

This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Therapeutic action

Cardiotonic.

Indications

  • Supraventricular arrhythmias such as fibrillation, flutter, and paroxysmal tachycardia.
  • Heart failure.

Forms and strengths

  • 250 micrograms (0.25 mg) tablet.

Dose

Adult: 125 to 250 micrograms (0.125 to 0.25 mg) once daily.

Reduce the dose by half in older patients and in patients with renal impairment.

Duration

According to clinical response.

Contra-indications, adverse effects, precautions

  • Do not administer to patients with bradycardia, ill-defined arrhythmia, or coronary artery disease.
  • It is essential to monitor heart rate in the initial stage of treatment.
  • Overdose may cause gastrointestinal disturbances, blurred vision, headache, confusion, and conduction or rhythm disorders. If so, reduce dose or stop treatment.
  • Do not combine with calcium, particularly by IV route, because serious arrhythmias may occur.
  • Monitor combination with amiodarone, macrolides, itraconazole, quinine, and chloroquine because digoxin concentration increases.
  • Potassium-depleting drugs such as diuretics, corticosteroids, and amphotericin B increase the risk of digoxin toxicity.
  • If possible, monitor serum potassium in patients taking potassium-depleting drugs and serum creatinine in patients with renal impairment.
  • Do not administer simultaneously with antacids; administer 2 hours apart.
  • Pregnancy: no contra-indication.
  • Breast-feeding: no contra-indication.

Source

MSF Essential drugs practical guidelines (January 2026)

This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.

Rate this guide

Be the first to rate this guide.